UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis

Clinical and experimental immunology, 2013-11, Vol.101 (2), p.220-226

2013

Volltextzugriff (PDF)

Intravenous immunoglobulin for ANCA‐associated systemic vasculitis with persistent disease activity

QJM : An International Journal of Medicine, 2000-07, Vol.93 (7), p.433-439

2000

Volltextzugriff (PDF)

The intermediate endpoint effect in logistic and probit regression

Clinical trials (London, England), 2007-01, Vol.4 (5), p.499-513

2007

Volltextzugriff (PDF)

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H

British journal of rheumatology, 2003-12, Vol.42 (12), p.1539-1544

2003

Volltextzugriff (PDF)

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen‐ and antigen‐stimulated human peripheral blood mononuclear cell cultures

Clinical and experimental immunology, 1995-02, Vol.99 (2), p.160-167

1995

Volltextzugriff (PDF)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

The Lancet (British edition), 1993-06, Vol.341 (8861), p.1620-1622

1993

Volltextzugriff (PDF)

Bactericidal/permeability‐increasing protein (BPI) is an important antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis

Clinical and experimental immunology, 1995-01, Vol.99 (1), p.49-56

1995

Volltextzugriff (PDF)

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies

Kidney international, 1999-03, Vol.55 (3), p.917-925

1999

Volltextzugriff (PDF)

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

The Lancet (British edition), 1991-05, Vol.337 (8750), p.1137-1139

1991

Volltextzugriff (PDF)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies

QJM : An International Journal of Medicine, 1996-12, Vol.89 (12), p.903-912

1996

Volltextzugriff (PDF)

Anti‐neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability‐increasing protein (BPI) and cystic fibrosis lung disease

Clinical and experimental immunology, 1999-09, Vol.117 (3), p.561-567

1999

Volltextzugriff (PDF)

Catalase and α‐enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD)

Clinical and experimental immunology, 1998-04, Vol.112 (1), p.10-16

1998

Volltextzugriff (PDF)

ANCA and predicting relapse in systemic vasculitis

QJM : An International Journal of Medicine, 1995-02, Vol.88 (2), p.127-133

1995

Volltextzugriff (PDF)

Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease

Gut, 1997-01, Vol.40 (1), p.105-109

1997

Volltextzugriff (PDF)

Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis

QJM : An International Journal of Medicine, 1996-04, Vol.89 (4), p.259-266

1996

Volltextzugriff (PDF)

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) A report on the second phase of an international cooperative study on the standardization of ANCA assays

Journal of immunological methods, 1996-09, Vol.196 (1), p.1-15

1996

Volltextzugriff (PDF)

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

Kidney international, 1991-10, Vol.40 (4), p.757-763

1991

Volltextzugriff (PDF)

New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy

Clinical and experimental immunology, 1996-05, Vol.104 (Supplement_1), p.77-82

Lock Wood, C. M.

1996

Volltextzugriff (PDF)

Tracheal involvement in wegener's granulomatosis: evaluation using spiral CT

Clinical radiology, 1998-11, Vol.53 (11), p.809-815

1998

Volltextzugriff (PDF)

Human autoimmune anti‐proteinase 3 scFv from a phage display library

Clinical and experimental immunology, 1997-02, Vol.107 (2), p.269-281

1997

Volltextzugriff (PDF)

Distribution of the product confidence limits for the indirect effect: program PRODCLIN

Behavior research methods, 2007-08, Vol.39 (3), p.384-389

2007

Volltextzugriff (PDF)

Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis

Kidney international, 1990-03, Vol.37 (3), p.965-970

1990

Volltextzugriff (PDF)

Azurocidin is a novel antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis

Clinical and experimental immunology, 1996-03, Vol.103 (3), p.397-402

1996

Volltextzugriff (PDF)

Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation

Clinical immunology (Orlando, Fla.), 1999-11, Vol.93 (2), p.93-106

1999

Volltextzugriff (PDF)

Antigen specificity in hydralazine associated ANCA positive systemic vasculitis

QJM : An International Journal of Medicine, 1995-11, Vol.88 (11), p.775-783

1995

Volltextzugriff (PDF)

1 – 25 von 1.392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.169)
Mit Volltextzugriff
(1.110)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis

Intravenous immunoglobulin for ANCA‐associated systemic vasculitis with persistent disease activity

The intermediate endpoint effect in logistic and probit regression

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen‐ and antigen‐stimulated human peripheral blood mononuclear cell cultures

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

Bactericidal/permeability‐increasing protein (BPI) is an important antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies

Anti‐neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability‐increasing protein (BPI) and cystic fibrosis lung disease

Catalase and α‐enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD)

ANCA and predicting relapse in systemic vasculitis

Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease

Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) A report on the second phase of an international cooperative study on the standardization of ANCA assays

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy

Tracheal involvement in wegener's granulomatosis: evaluation using spiral CT

Human autoimmune anti‐proteinase 3 scFv from a phage display library

Distribution of the product confidence limits for the indirect effect: program PRODCLIN

Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis

Azurocidin is a novel antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis

Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation

Antigen specificity in hydralazine associated ANCA positive systemic vasculitis

Suchergebnisse filtern